Skip to content

ABT

Abbott Laboratories

Operating income, 2025
$8.1B
YoY, 2025
+18.0%
5-year CAGR
+8.5%
10-year CAGR
+10.9%

Operating income

Operating income by fiscal year

PeriodOperating incomeYoY
2025$8.1B+18.0%
2024$6.8B+5.4%
2023$6.5B−22.5%
2022$8.4B−0.7%
2021$8.4B+57.3%
2020$5.4B+18.2%
2019$4.5B+24.2%
2018$3.7B+133.4%
2017$1.6B−48.3%
2016$3.0B+5.5%
2015$2.9B+10.3%
2014$2.6B+21.8%
2013$2.1B+56.8%
2012$1.4B−16.5%
2011$1.6B−73.2%
2010$6.1B−2.4%
2009$6.2B+9.5%
2008$5.7B+24.4%
2007$4.6B—